Skip to content

Chronic Pain Self-management for Older Adults With Cognitive Impairment: A Randomized Pilot Trial

Chronic Pain Self-management for Older Adults With Cognitive Impairment: A Randomized Pilot Trial

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06182423
Acronym
STEPS-CI
Enrollment
57
Registered
2023-12-26
Start date
2024-06-25
Completion date
2025-06-11
Last updated
2026-05-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Pain, Cognitive Impairment

Brief summary

The goal of this randomized pilot trial is to test a chronic pain self-management program customized for people living with both chronic pain and cognitive impairment. The main questions it aims to answer are whether this program is feasible and acceptable, and whether it shows potential for improving pain-related outcomes. Intervention group participants will receive education and support from a community health worker in 7 weekly telephone sessions, and will watch a series of educational videos discussing a variety of chronic pain self-management skills. A control group will not receive the program, but after the final data collection point will be invited to attend a one-time remote session that summarizes intervention content, and will receive all program materials. Researchers will compare intervention and control groups after the program ends to see if the intervention group has less pain interference with daily activities.

Interventions

BEHAVIORALSTEPS-CI (Support, Training, and Education for Pain Self-management- Cognitively Inclusive version)

This intervention is a community health worker (CHW)-led chronic pain self-management program designed for older adults with chronic pain and mild to moderate cognitive impairment. It is a 7-week intervention that includes two primary components: a website that includes brief instructional videos on pain management skills as well as testimonials from individuals living with the two target health conditions; and weekly telephone sessions with a CHW to support and motivate participants in setting goals related to pain management. Reminder strategies and content addressing pain management challenges related to cognitive impairment are incorporated throughout. Participants may choose to work with a care partner during intervention activities.

Sponsors

University of Michigan
Lead SponsorOTHER
National Institute on Aging (NIA)
CollaboratorNIH

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
50 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age \> 50 years; * Have a cell or landline phone and internet access; * Self-reported chronic musculoskeletal pain (pain in muscles or joints for \> 3 months); \>1 day/previous 30 when pain made it difficult to do usual activities. * Self-reported mild cognitive impairment (MCI)/memory difficulties that at least sometimes interfere with usual daily activities * Willingness to meet by phone or video with a community health worker to learn potentially new ways to manage pain and commit to the duration of the program * Able to converse comfortably in English.

Exclusion criteria

* Serious acute illness or hospitalization in last month; planned major surgery in next three months that would interfere with program participation (e.g., knee replacement) * Other issues that are judged by study team to preclude meaningful participation in study procedures (e.g. severe physical, cognitive, or psychiatric disorder). * Current or prior participation in the parent STEPS study or the RESET (Re-Engaging in Self-Care and Enjoying Today) Study.

Design outcomes

Primary

MeasureTime frameDescription
Change in Pain InterferenceBaseline, 10 weeks from baselineThe Pain Interference 6-item subscale of the Patient-Reported Outcomes Measurement Information System (PROMIS)-43 Adult Profile. Items ask how much pain in the last 7 days has interfered with daily activities such as household chores and social activities (1=not at all to 5=very much); raw total scale scores range from 6 (low interference) to 30 (high interference). When converted to T-scores (normed such that a score of 50 is the population mean and 10 T-score points=1 standard deviation), the possible range is 42 to 76, with a higher score representing a worse outcome. Change score represents \[follow-up score - baseline score\].

Secondary

MeasureTime frameDescription
Change in Pain IntensityBaseline, 10 weeks from baselineA numeric rating scale of pain in the last week ranging from 0 (no pain at all; best outcome) to 10 (worst pain you can imagine; worst outcome). Change score represents \[follow-up score - baseline score\].
Change in Subjective Cognitive FunctioningBaseline, 10 weeks from baselineThe 4-item PROMIS Cognitive Function-Abilities Short Form 4a V. 2.0 measures perceived cognitive functioning in the last 4 days (e.g., "My mind has been as sharp as usual") on a scale from 1=not at all to 5=very much. Scores are converted to a standardized T-score metric, with a mean of 50 and a standard deviation of 10 in a referent population. A higher score means better cognitive functioning. Change score represents \[follow-up score - baseline score\].

Countries

United States

Baseline characteristics

Characteristic
Age, Continuous68.2 years
STANDARD_DEVIATION 12
Ethnicity (NIH/OMB)
Hispanic or Latino
1 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
54 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants
Pain intensity5.9 score on a scale
STANDARD_DEVIATION 2
Pain Interference60.9 score on a scale
STANDARD_DEVIATION 7.5
Race (NIH/OMB)
American Indian or Alaska Native
1 Participants
Race (NIH/OMB)
Asian
0 Participants
Race (NIH/OMB)
Black or African American
10 Participants
Race (NIH/OMB)
More than one race
2 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
Race (NIH/OMB)
Unknown or Not Reported
3 Participants
Race (NIH/OMB)
White
28 Participants
Sex: Female, Male
Female
22 Participants
Sex: Female, Male
Male
5 Participants
Subjective cognitive functioning43.6 units on a scale
STANDARD_DEVIATION 6.6

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 280 / 29
other
Total, other adverse events
0 / 280 / 29
serious
Total, serious adverse events
1 / 280 / 29

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 23, 2026